1050 related articles for article (PubMed ID: 23773522)
1. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological actions of neferine in the modulation of human platelet function.
Yang RP; Zhou YJ; Song W; Yin Z; He AD; Ming ZY
Eur J Pharmacol; 2019 Nov; 862():172626. PubMed ID: 31445013
[TBL] [Abstract][Full Text] [Related]
3. 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (THSG) attenuates human platelet aggregation, secretion and spreading in vitro.
Xiang K; Liu G; Zhou YJ; Hao HZ; Yin Z; He AD; Da XW; Xiang JZ; Wang JL; Ming ZY
Thromb Res; 2014 Feb; 133(2):211-7. PubMed ID: 24332167
[TBL] [Abstract][Full Text] [Related]
4. [Effects of neferine and its combination with taurine on platelet aggregation and experimental thrombosis in rats].
Huang HL; Rao MR
Yao Xue Xue Bao; 1995; 30(7):486-90. PubMed ID: 7484155
[TBL] [Abstract][Full Text] [Related]
5. [Effects of neferine on platelet aggregation in rabbits].
Yu J; Hu WS
Yao Xue Xue Bao; 1997; 32(1):1-4. PubMed ID: 11243209
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim KS; Hong JH; Kwak YS; Yun BS; Rhee MH
J Ethnopharmacol; 2010 Aug; 130(3):614-20. PubMed ID: 20558266
[TBL] [Abstract][Full Text] [Related]
7. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.
Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N
Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576
[TBL] [Abstract][Full Text] [Related]
9. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats.
Song Q; Wang S; Zhao W
J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological properties of the novel anti-platelet aggregating agent 4-cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid.
Fujimori T; Harada K; Saeki T; Kogushi M; Akasaka K; Yamagishi Y; Yamatsu I
Arzneimittelforschung; 1987 Oct; 37(10):1143-8. PubMed ID: 3124862
[TBL] [Abstract][Full Text] [Related]
11. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
12. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
13. Novel antiplatelet activity of protocatechuic acid through the inhibition of high shear stress-induced platelet aggregation.
Kim K; Bae ON; Lim KM; Noh JY; Kang S; Chung KY; Chung JH
J Pharmacol Exp Ther; 2012 Dec; 343(3):704-11. PubMed ID: 22984226
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
[TBL] [Abstract][Full Text] [Related]
15. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
17. The metalloprotease, NN-PF3 from Naja naja venom inhibits platelet aggregation primarily by affecting α2β1 integrin.
Kumar MS; Girish KS; Vishwanath BS; Kemparaju K
Ann Hematol; 2011 May; 90(5):569-77. PubMed ID: 20957364
[TBL] [Abstract][Full Text] [Related]
18. Pentamethylquercetin (PMQ) reduces thrombus formation by inhibiting platelet function.
Liang ML; Da XW; He AD; Yao GQ; Xie W; Liu G; Xiang JZ; Ming ZY
Sci Rep; 2015 Jun; 5():11142. PubMed ID: 26059557
[TBL] [Abstract][Full Text] [Related]
19. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
20. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
Azzam K; Cissé-Thiam M; Drouet L
Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]